From: A prognostic model using FIGO 2018 staging and MRI-derived tumor volume to predict long-term outcomes in patients with uterine cervical squamous cell carcinoma who received definitive radiotherapy
Group
Nomogram
(95%CI)
FIGO2018
Training set
0.74 (0.67–0.80)
0.66 (0.59–0.73)
Validation set
0.70 (0.57–0.82)
0.63 (0.52–0.75)